Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
Clinical trial NCT04044170 · TERMINATED
Trial details
- NCT number
- NCT04044170
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2020-04-13
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.